Types of clinical trials vary widely depending on their purpose, design, and the phase of research they represent. Clinical trials are research studies performed in people that aim to evaluate medical, surgical, or behavioral interventions.
They are the primary method researchers use to determine whether a new treatment, drug, medical device, or behavioral approach is safe and effective. Understanding the different types of clinical trials helps patients, sponsors, and investigators make informed decisions about participation and study design.
Interventional vs. Observational Studies
There are two main categories of types of clinical trials: interventional and observational.
Interventional trials aim to learn more about a specific treatment or intervention. Participants are assigned to different treatment groups so that the research team can compare outcomes across those groups. These are the trials most people picture when they think of clinical research.
Observational studies take a different approach. The research team monitors participants in different situations without influencing which treatments they receive. Participants are not placed into treatment groups. Instead, researchers observe what happens naturally and draw conclusions from that data.
Within these two broad categories, there are several specific types of clinical trials including pilot and feasibility studies, prevention trials, screening trials, treatment trials, multi arm multi stage trials, cohort studies, case control studies, and cross sectional studies. Each serves a distinct scientific purpose and addresses different research questions.
The 4 Phases of Clinical Trials
One of the most important distinctions among types of clinical trials is the phase in which they occur. Clinical trials testing new treatments are divided into phases, each with its own objectives, typical participant numbers, and level of randomization.
| Phase | Number of people taking part | Main aims of trial | Is it randomized? |
| 0 | Small – often about 10 to 20 people | Testing a low dose to confirm it is not harmful | No |
1 | Small – often about 20 to 50 people | Evaluating side effects and how the treatment behaves in the body | No |
2 | Variable | Assessing side effects in more detail and early effectiveness | Sometimes |
| 3 | Large — hundreds or thousands | Comparing the new treatment to the existing standard of care | Usually |
| 4 | Medium to large, variable | Evaluating long term benefits and side effects after approval | No |
Phase 0 and Phase 1 trials focus primarily on safety. Phase 2 begins to examine whether the treatment actually works. Phase 3 generates the pivotal data regulators need to approve a new treatment. Phase 4 takes place after approval and monitors real world performance in larger and more diverse populations.
Understanding these phases is essential for sponsors when designing clinical trial programs and selecting sites capable of supporting each stage. Types of clinical trials at Phase 3 and Phase 4 require sites with large patient networks, strong regulatory infrastructure, and the operational capacity to manage complex multi site studies.
Randomized Controlled Trials
Among all types of clinical trials, the randomized controlled trial (RCT) is considered the gold standard for evaluating whether an intervention truly works. In an RCT, participants are assigned at random to a treatment group or a control group.
This random assignment eliminates selection bias and makes it possible to attribute observed differences in outcomes directly to the treatment being tested rather than to other variables.
The simplest RCT design includes one treatment arm and one control group. More complex designs may include multiple treatment arms, allowing researchers to compare several interventions simultaneously. A factorial design adds a third arm in which participants receive more than one intervention at once.
In settings where an existing standard treatment is already in use, the control group typically continues to receive that existing treatment. This allows the RCT to measure not just whether a new intervention works, but whether it works better than what is already available.
Cluster randomized trials assign groups of participants rather than individuals to treatment arms. This design is common in education and nutrition research, where the intervention is delivered at the community, school, or district level rather than to individual participants.
For example, an education intervention might be assigned at the school level even though the effects are measured at the level of the individual child. Similarly, a nutrition intervention might be assigned at the community or sub district level. In both cases, the cluster design reflects practical and ethical constraints that make individual level randomization difficult or inappropriate.
FOMAT and the Full Spectrum of Clinical Research
FOMAT conducts all types of clinical trials across a broad range of therapeutic areas including oncology, nephrology, ophthalmology, infectious disease, and gastroenterology.
Our network of investigator sites across the United States supports sponsors and CROs from early Phase I studies through large Phase III pivotal trials and Phase IV post market research. Our experience across all types of clinical trials makes us a reliable partner for sponsors seeking to execute complex multi-phase programs.
To learn more about our Phase II and III capabilities or to explore our active studies, visit fomatmedical.com.
Source: UNICEF